October 29, 2025 - 01:19

In a landmark move for pediatric healthcare, UVM Health's children’s hospital has been awarded a staggering $25 million donation from billionaire philanthropist Tom Golisano. This generous contribution marks the largest single donation ever received by the pediatric care center, positioning it for significant advancements in the quality of care it provides.
The funding is set to enhance the hospital's capabilities, facilitating an alliance with nine other leading children’s hospitals across the nation. This collaboration aims to foster innovation and improve pediatric healthcare practices, ensuring that children receive the best possible treatment available.
Golisano, a well-known advocate for children’s health initiatives, has long been committed to improving healthcare access and quality for young patients. His latest donation is expected to catalyze further investments and partnerships, ultimately benefiting countless families in the region and beyond. This transformative gift underscores the vital importance of philanthropic support in advancing healthcare for children.
October 28, 2025 - 09:53
Embracing Community Through Health and CompassionIn 2003, a significant social statement was released that emphasizes the importance of justice and love in the realm of health care. This document highlights the vital role that health care...
October 27, 2025 - 18:46
“People Can Die” from Gaps in Nutrition, Experts Warn Ahead of SNAP Benefits DelayAs the November deadline approaches for the distribution of Supplemental Nutrition Assistance Program (SNAP) benefits, health experts are sounding the alarm about the potential consequences of food...
October 27, 2025 - 13:42
Malala Yousafzai Engages Audience on Mental Health and New BookThe event, part of Yousafzai’s “Finding My Way” book tour, took place Sunday evening and drew over a thousand attendees. The atmosphere was charged with excitement as the Nobel laureate...
October 26, 2025 - 21:25
Mepolizumab Proves Effective in Reducing Healthcare Burdens for Severe Asthma PatientsRecent real-world data highlights the long-term benefits of mepolizumab as an add-on maintenance therapy for individuals suffering from severe asthma. This monoclonal antibody has been shown to...